"The Effect of the Cord Clamping Bundle at Birth Developed With the Delphi Method on Maternal and Newborn Outcomes" (Cord Clamping)

July 8, 2026 updated by: Elif MARANGOZ

This clinical trial aims to evaluate the effects of a cord clamping bundle developed through the Delphi method on maternal and neonatal outcomes. The study population consists of primiparous women with singleton term pregnancies (37-42 weeks of gestation) who undergo vaginal delivery, along with their healthy newborns.

The primary research questions are:

Does the Delphi-based cord clamping bundle improve maternal and neonatal physiological outcomes? Does the Delphi-based cord clamping bundle enhance mother-infant bonding and breastfeeding success?

Comparison Group:

Researchers will compare the intervention group, in which the cord clamping bundle is implemented, with the control group receiving routine clinical care to determine the effects of the intervention on maternal and neonatal outcomes.

Participant Involvement:

Participants will provide written and verbal informed consent and complete a personal information form. Following delivery, participants will receive either the cord clamping bundle intervention or routine care according to their assigned group. Data collection will be conducted within the first 24 hours postpartum and will include:

Maternal and neonatal physiological parameters Breastfeeding success assessed using the LATCH Breastfeeding Assessment Tool Mother-infant bonding assessed using the Mother-to-Infant Bonding Scale Amount of postpartum bleeding Placental separation time Time to initiation of breastfeeding Length of hospital stay after delivery.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This study aims to evaluate the effects of a cord clamping bundle developed using the Delphi technique on maternal and neonatal outcomes following term vaginal birth. The bundle was developed based on expert consensus to standardize cord clamping practices during the immediate postpartum period.

The study will be conducted among primiparous women with singleton term pregnancies who undergo vaginal delivery and their healthy newborns. Participants will be assigned to either an intervention group receiving the cord clamping bundle or a control group receiving routine cord clamping care according to hospital practice.

Maternal and neonatal physiological outcomes, breastfeeding success, mother-infant bonding, postpartum bleeding, placental separation time, time to initiation of breastfeeding, and length of hospital stay will be evaluated within the first 24 hours after birth. Breastfeeding success will be assessed using the LATCH Breastfeeding Assessment Tool, and mother-infant bonding will be assessed using the Mother-to-Infant Bonding Scale. The findings are expected to contribute to evidence-based cord clamping practices and improve maternal and neonatal care outcomes.BizChat hakkında geri bildirim gönderin

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Primiparous women Singleton pregnancy Term pregnancy (37-42 weeks of gestation) Vaginal delivery Healthy newborn Mother and newborn discharged together Age 18 years or older Willingness to participate and provide written informed consent

Exclusion Criteria:

High-risk pregnancy Maternal chronic disease Maternal or neonatal conditions affecting breastfeeding Newborn with intrauterine growth restriction (IUGR) Newborn with a genetic disorder or congenital anomaly Operative or assisted vaginal delivery requiring obstetric intervention Refusal to participate or withdrawal from the study Incomplete study data or inability to complete outcome assessments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cord Clamping Bundle Group

Experimental Arm (Cord Clamping Bundle Group)

Intervention:

Delphi-Based Cord Clamping Bundle

Participants in this arm will receive the Delphi-based cord clamping bundle. The bundle includes preparation of sterile materials, delayed cord clamping until cord pulsations cease (at least 1-3 minutes), cord clamping with a sterile umbilical clamp, cutting the cord 4-5 cm from the skin using sterile scissors, and maintaining dry cord care.
Other: Cord Clamping Bundle
A standardized cord clamping bundle developed through the Delphi technique based on expert consensus. The intervention includes preparation of sterile materials, delayed umbilical cord clamping until cord pulsations cease (at least 1-3 minutes after birth), sterile cord clamping and cutting, and maintenance of dry cord care.
Active Comparator: Routine Cord Clamping Group
Routine umbilical cord clamping and postpartum care provided according to the hospital's standard clinical practice without implementation of the cord clamping bundle.
Other: Routine Cord Clamping Care
Routine umbilical cord clamping and postpartum care provided according to the hospital's standard clinical practice without implementation of the cord clamping bundle.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mother-Infant Bonding
Time Frame: First 24 hours after birth
Mother-infant bonding assessed using the Mother-to-Infant Bonding Scale.
First 24 hours after birth

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mother-Infant Bonding
Time Frame: First 24 hours after birth
Mother-infant bonding assessed using the Mother-to-Infant Bonding Scale.
First 24 hours after birth

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neonatal Hemoglobin Level (if measured)
Time Frame: First 24 hours after birth

Neonatal hemoglobin concentration.

Unit of Measure: g/dL
First 24 hours after birth
Neonatal Hematocrit Level (if measured)
Time Frame: First 24 hours after birth
Neonatal hematocrit percentage. Unit of Measure: %
First 24 hours after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Elif MARANGOZ

Collaborators

Istanbul University - Cerrahpasa

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

August 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

July 2, 2026

First Submitted That Met QC Criteria

July 8, 2026

First Posted (Actual)

July 14, 2026

Study Record Updates

Last Update Posted (Actual)

July 14, 2026

Last Update Submitted That Met QC Criteria

July 8, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • CSCH-2025-290

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) collected during this study will not be made publicly available due to ethical and confidentiality considerations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Effects of a Cord Clamping Bundle on Maternal and Neonatal Outcomes

Clinical Trials on Cord Clamping Bundle

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe